Journals / Türk Nöroşirürji Dergsi / 2020 / Cilt: 30 - Sayı: 2

Therapeutic Strategies for Repair and Regeneration in Traumatic Brain Injury Cases

Travmatik Beyin Hasarlı Olgularda Tamir ve Rejenerasyon İçin Terapötik Stratejiler

Pages
224–228
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These options are described in stages, subdivided according to their mechanism of effect.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Traumatic brain injury is one of the most important causes of mortality and morbidity in young adults, especially in men.
📊
Key Findings & Data:It creates serious burdens for patients, their families, and social security institutions.
💡
Conclusion & Impact:These options are described in stages, subdivided according to their mechanism of effect.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Traumatic brain injury is one of the most important causes of mortality and morbidity in young adults, especially in men. It creates serious burdens for patients, their families, and social security institutions. It can lead to prolonged restrictions and injuries. The primary injury is irreversible, but it is sometimes possible to prevent or reverse secondary injury with surgical methods or medical treatments. As the pathophysiology of secondary injury becomes better understood, preventive and regenerative therapeutic options emerge and are developed. Treatment modalities have been determined through extensive literature reviews about therapeutic options. The therapeutic options specified for traumatic brain injury are described in this article. These options are described in stages, subdivided according to their mechanism of effect.

Özet

Travmatik beyin hasarı genç erişkinlerde, özellikle erkeklerde mortalite ve morbiditenin en önemli nedenlerinden birisidir. Hem hastalarhem aileleri, hem de sosyal güvenlik kurumları için oldukça ciddi yükler doğurmaktadır. Uzun süren kısıtlanmalar ve sakatlıklarayol açabilir. Primer yaralanma geri dönüşümsüzdür ancak sekonder yaralanmayı engellemek veya geri döndürmek bazen cerrahiyollardan bazen de medikal tedavilerle mümkün olabilmektedir. Sekonder yaralanmaya ait patofizyoloji anlaşıldıkça koruyucu veiyileştirici terapötik seçenekler ortaya çıkmakta ve gelişmektedir. Terapötik seçenekler ile ilgili geniş literatür taraması yapılaraktedavi seçenekleri saptanmıştır. Çalışmamızda travmatik beyin hasarı için belirtilen terapötik seçenekler anlatılmıştır. Terapötik tedaviseçenekleri etki mekanizmalarına göre kademeli olarak alt başlıklara ayrılarak anlatılmıştır.

🔖

Cite This Article

İŞTEMEN, İ., ÖKTEN, A. İ. (2022). Therapeutic Strategies for Repair and Regeneration in Traumatic Brain Injury Cases. Türk Nöroşirürji Dergsi, Cilt: 30 - Sayı: 2, 224–228. https://ajindex.com/articles/637203

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Bailey I, Bell A, Gray J, Gullan R, Heiskanan O, Marks PV, Marsh H, Mendelow DA, Murray G, Ohman J, Quaghebeur G, Sina J, Skene A, Teasdale G, Waters A: A trial of the effect of nimodipine on outcome after head injury. Acta Neurochir 110: 97-105, 1991 2. Boato F, Hendrix S, Huelsenbeck SC, Hofmann F, Grosse G, Djalali S, Klimaschewski L, Auer M, Just I, Ahnert-Hilger G, Höltje M: C3 peptide enhances recovery from spinal cord injury by improved regenerative growth of descending fiber tracts. J Cell Sci 123:1652-1662, 2010 3. Chiaretti A, Antonelli A, Mastrangelo A, Pezzotti P, Tortorolo L, Tosi F, Genovese O: Interleukin-6 and nerve growth factor upregulation correlates with improved outcome in children with severe traumatic brain injury. J Neurotrauma 25:225-234, 2008 4. Chiaretti A, Barone G, Riccardi R, Antonelli A, Pezzotti P, Genovese O, Tortorolo L, Conti G: NGF, DCX and NSE upregulation correlates with severity and outcome of head trauma in children. Neurology 72:609-616, 2009 5. Chopp M, Zhang ZG: Emerging potential of exosomes and noncoding microRNAs for the treatment of neurological injury/ diseases. Expert Opin Emerg Drugs 20:523-526, 2015 6. Cox CS, Baumgartner JE, Harting MT, Worth LL, Walker PA, Shah SK, Ewing-Cobbs L, Hasan KM, Day MC, Lee D, Jimenez F, Gee A: Autologous bone marrow mononuclear cell therapy for severe traumatic brain injury in children. Neurosurgery 68: 588-600, 2011 7. Czeiter E, Büki A, Bukovics P, Farkas O, Pál J, Kövesdi E, Dóczi T, Sándor J: Calpain inhibition reduces axolemmal leakage in traumatic axonal injury. Molecules 14:5115-5123, 2009 8. Dewan MC, Rattani A, Gupta S, Baticulon RE, Hung YC, Punchak M, Agrawal A, Adeleye AO, Shrime MG, Rubiano AM, Rosenfeld JV, Park KB: Estimating the global incidence of traumatic brain injury. J Neurosurg 1:1-18, 2018 9. Dixon CE, Flinn P, Bao J, Venya R, Hayes RL: Nerve growth factor attenuates cholinergic deficits following traumatic brain injury in rats. Exp Neurol 146:479-490, 1997 10. Finkelstein E, Corso PS, Miller TR: The Incidence and Economic Burden of Injuries in the United States. New York: Oxford University Press, 2006 11. Galindo LT, Filippo TRM, Semedo P, Ariza CB, Moreira CM, Camara NOS, Porcionatto MA: Mesenchymal stem cell therapy modulates the inflammatory response in experimental traumatic brain injury. Neurol Res Int 2011: 564089, 2011 12. Garrido-Mesa N, Zarzuelo A, Galvez J: Minocycline: Far beyond an antibiotic. Br J Pharmacol 169:337-352, 2013 13. Höltje